EID Parry India Limited
EID Parry is engaged in Sugar, Nutraceuticals and ethanol production. It also has a significant presence in the Farm Inputs business including Bio pesticides through its subsidiary, Coromandel International Limited.
What EID files
- Others73
- Important25
- Investor Meet24
- Updates15
- Board Meeting13
- Credit Ratings1
E.I.D. - Parry received a "Strong" ESG Rating of 61 from CRISIL for FY 2025-26. This independent assessment, based on public information, highlights the company's robust environmental, social, and governance practices.
E.I.D.-Parry will hold its 51st Annual General Meeting (AGM) via video conferencing on August 12. The Annual Report for FY25-26 is out. Remote e-voting for shareholders is from August 8-11. Eligibility for voting is set by the August 5 cut-off date.
EID Parry reported a standalone FY26 loss of ₹708 Cr, largely due to ₹992 Cr in provisions/impairments from PSRIPL's closure and ₹138 Cr PPE impairment. This was partially offset by a ₹298 Cr gain from selling a CIL stake. Consolidated profit was ₹570 Cr.
EID Parry reports a Q4 consolidated loss of Rs. 333 Cr, impacted by the closure of its unviable sugar refinery and associated provisions. Strategic portfolio shifts include selling a CIL stake and CIL's acquisition of NACL Industries.
EID Parry closed its PSRIPL sugar refinery, incurring Rs. 591 Cr provision and Rs. 401 Cr impairment. Q4 and FY standalone losses reported. Company sold Coromandel stake for Rs. 298 Cr gain. Strategic shifts are underway in CPG, Nutraceuticals; Sugar segment showed improved profitability.